Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis

Combines bioproduction and pharma services to accelerate innovation in biologics manufacturing

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO

Applied Biosystems RapidHIT ID System plays key role in arrestee testing and investigative lead generation

New facility in Lenexa, Kansas built in six weeks to rapidly expand production of viral transport media